Initiation and discontinuation of complementary therapy among cancer patients

Sung Gyeong Kim, Eun Cheol Park, Jae Hyun Park, Myung Il Hahm, Jin Hwa Lim, Kui Son Choi

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Purpose: To identify the initiation or discontinuation of complementary therapy (CT) and determine the impact of sociodemographic and clinical factors on CT use among cancer patients. Patients and Methods: Eligible patients were age 20 or older; newly diagnosed with stomach, liver, or colorectal cancer; and started their initial treatment at the National Cancer Center, Korea, between April 1, 2001, and April 30, 2003. In total, 541 cancer patients were surveyed in face-to-face interviews at baseline, and telephone follow-up interviews were performed every 3 months for 3 years. Results: A total of 281 patients commenced CT after diagnosis; 164 patients stopped using CT during the follow-up period. The overall cumulative probability of starting CT at 1, 2, and 3 years was 50%, 54%, and 55%, respectively. In a Cox multivariate analysis, stomach and liver cancer were associated with an increased probability of initiating CT compared with colorectal cancer. Patients who were classified as stage I, II, or III at diagnosis were associated with a decreased probability of discontinuing CT compared with stage IV. Conclusion: Most cancer patients started to use CT during the initial treatment period. Thus, physicians should communicate with cancer patients about CT at this phase. In particular, more attention should be paid to women and individuals with higher household incomes because these groups are more likely to start CT.

Original languageEnglish
Pages (from-to)5267-5274
Number of pages8
JournalJournal of Clinical Oncology
Volume25
Issue number33
DOIs
Publication statusPublished - 2007 Nov 20

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'Initiation and discontinuation of complementary therapy among cancer patients'. Together they form a unique fingerprint.

  • Cite this